Barbara Parodi, born in Genova, March 22nd, 1956. In 1983 degree in Medicine and Surgery, University of Genova.
Since 1984, employee at the National Cancer Institute (IST) of Genoa; since 2003, responsible of the core facility of IST “Biological Bank and Cell Factory”.
Research activity: Studies on T - B cell interaction in the immune response, role of HLA in the immune response.
Expertise: management, quality assurance and quality control in biobanks / Biological Resource Centres; Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP).
Institutional role: Executive manager of the IST Biological Resource Centre (CRB-IST). Chair of the subgroup “Parameters” of the international working group “BioResource Impact Factor”; member of: the Scientific Advisory Board of the Telethon Genetic Biobank Network; the VAS (Vascular independent research and education European organization) European Teaching Panel; the Scientific Advisory Board of the CHRIS (Cooperative Health Research in South Tyrol) Study; the Steering Committee of the Italian national node of BBMRI; the Regional network of biobanks of Liguria. Partner in BBMRI, GBRCN, MIRRI. Coordination of the Italian participation to the preparatory phase of the European biobank infrastructure BBMRI. Qualified person for the production of cells for therapy, nominated by the Italian Agenzia del Farmaco (decree N. AIDT – 9/2004, L. 178/91). Delegate of the Italian Minister of Research at the OECD Task Force on BRCs. Compilation of the OECD Best Practice Guidelines for Biological Resource centres.
Author of 51 scientific publications on national and international Journals, 3 international guidelines and 79 abstracts.